Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Germicidal ultraviolet to reduce transmission of respiratory infections indoors: a systematic review.

    Oct 26, 2026DOI: 10.1017/ice.2026.10549Journal ArticleICHE

    Written by: Grant P Higerd-RusliErin C StoneSeth A HoffmanErnest R BlatchleyDavid T KuharStephen P LubyStephen B MartinRichard A MartinelloC Cameron MillerKatherine RatliffDavid H SlineyJoanna M TalianoDavid N WeissmanJoshua D WallachLewis J Radonovich

    Find these authors on Roon

    RM
    Dr. Richard Martinello
    General ID · Yale College

    Summary

    BACKGROUND: Respiratory infections that transmit through air contribute substantially to global morbidity and mortality. Although preclinical data on germicidal ultraviolet (GUV) for air treatment are promising, its real-world effectiveness remains incompletely understood.PURPOSE: Review effectiveness and safety of GUV for preventing respiratory infection transmission.DATA SOURCES: Medline, Embase, Global Health, Cochrane Library, CINAHL, Engineering Village, Epistemonikos, Scopus, and Environmental Science Collection from inception through December 2025.STUDY SELECTION: Studies of GUV with a comparator, measuring human outcomes including respiratory infections, absenteeism, or adverse events.DATA EXTRACTION: At least two investigators extracted data.DATA SYNTHESIS: We identified 57 reports describing 40 studies published between 1940 and 2025: 30 non-randomized controlled trials, 4 randomized controlled trials (RCTs), 4 case series, 1 cohort study, and 1 cross-sectional study. Non-randomized studies indicated GUV reduces infections with high transmissibility through air (measles and chickenpox), although results were mixed for undifferentiated respiratory illnesses and absenteeism. Two RCTs were inconclusive or showed only modest effects. Safety monitoring in 16 studies identified no increased eye or skin irritation from properly installed GUV. All studies had at least one threat to validity; 89% were non-randomized, and 83% lacked statistical power calculations.LIMITATIONS: Heterogeneous study designs, interventions, and outcomes precluded meta-analysis.CONCLUSIONS: Several older clinical studies indicated that GUV reduces infections with high transmissibility through air, but its broader effectiveness against respiratory infection remains uncertain. Inconclusive results may reflect methodological and epidemiological limitations rather than true ineffectiveness. Adequately powered RCTs with robust clinical endpoints are needed.
    REGISTRATION: https://osf.io/fg6qx.
    RMDr. Richard Martinello

    Dr. Richard Martinello

    Infectious Disease · General Infectious Disease
    Yale University
    richardm